Roflumilast treatment inhibits lung carcinogenesis in benzo (a) pyrene-induced murine lung cancer model

CD Yeo, YA Kim, HY Lee, JW Kim, SJ Kim… - European journal of …, 2017 - Elsevier
Roflumilast, a potent and selective inhibitor of phosphodiesterase-4 (PDE4), has been used
in treatment of COPD. PDE4 inhibitor is associated with inhibition of chronic airway …

Roflumilast treatment inhibits lung carcinogenesis in benzo (a) pyrene-induced murine lung cancer model.

CD Yeo, YA Kim, HY Lee, JW Kim, SJ Kim… - European Journal of …, 2017 - europepmc.org
Roflumilast, a potent and selective inhibitor of phosphodiesterase-4 (PDE4), has been used
in treatment of COPD. PDE4 inhibitor is associated with inhibition of chronic airway …

Roflumilast treatment inhibits lung carcinogenesis in benzo (a) pyrene-induced murine lung cancer model

CD Yeo, YA Kim, HY Lee, JW Kim, SJ Kim… - European Journal of …, 2017 - hero.epa.gov
Roflumilast, a potent and selective inhibitor of phosphodiesterase-4 (PDE4), has been used
in treatment of COPD. PDE4 inhibitor is associated with inhibition of chronic airway …

Roflumilast treatment inhibits lung carcinogenesis in benzo (a) pyrene-induced murine lung cancer model

CD Yeo, YA Kim, HY Lee, JW Kim… - European journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Roflumilast, a potent and selective inhibitor of phosphodiesterase-4 (PDE4), has been used
in treatment of COPD. PDE4 inhibitor is associated with inhibition of chronic airway …

Roflumilast treatment inhibits lung carcinogenesis in benzo (a) pyrene-induced murine lung cancer model

CD Yeo, YA Kim, HY Lee, JW Kim… - European Journal …, 2017 - cuk.elsevierpure.com
Roflumilast, a potent and selective inhibitor of phosphodiesterase-4 (PDE4), has been used
in treatment of COPD. PDE4 inhibitor is associated with inhibition of chronic airway …